Archives for October 15, 2024

← 2024

Sanofi abandons phase 2 trial of Denali’s multiple sclerosis candidate

15-Oct-2024

By Jonathan Smith

The big pharma company Sanofi has discontinued a phase 2 trial of U.S. partner Denali Therapeutics’ oditrasertib for the treatment of multiple sclerosis after the drug failed to perform.

How a CDMO is staying on top of API and drug product manufacturing trends

15-Oct-2024

By Larissa Worneck-Silvestrin

As active pharmaceutical ingredients (APIs) and medicines become more complex and the demand for efficiency rises, drug developers and manufacturers must adapt their strategies to keep pace with the evolving landscape.